Khalili, DavoodSaadati, HassanBaradaran, Hamid RezaHadaegh, FarzadSteyerberg, Ewout WWoodward, MarkDanaei, Goodarz2024-11-062024-11-062024-10-18Khalili, D, Saadati, H, Baradaran, H R, Hadaegh, F, Steyerberg, E W, Woodward, M & Danaei, G 2024, 'Optimal risk thresholds for prescribing statins as primary prevention of cardiovascular disease in Iranian general population : a benefit-harm modelling study', BMC Cardiovascular Disorders, vol. 24, 575. https://doi.org/10.1186/s12872-024-04242-x1471-2261ORCID: /0000-0002-5070-5864/work/171447404https://hdl.handle.net/2164/24567111189894engSDG 3 - Good Health and Well-beingHumansMiddle AgedHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic useMaleFemaleIran/epidemiologyAdultAgedCardiovascular Diseases/prevention & controlPrimary PreventionRisk AssessmentTreatment OutcomeAge FactorsSex FactorsDrug PrescriptionsHeart Disease Risk FactorsDecision Support TechniquesClinical Decision-MakingTime FactorsPractice Patterns, Physicians'R Medicine (General)R1Optimal risk thresholds for prescribing statins as primary prevention of cardiovascular disease in Iranian general population : a benefit-harm modelling studyJournal article10.1186/s12872-024-04242-x24